Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03305081 · ClinicalTrials.gov registry record · NA
Patient Compliance With Long-Acting Reversible Contraception Administration
A NA study, sponsored by Tulane University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03305081 is a NA study that was terminated before completion, run by Tulane University School of Medicine. The registered enrollment target is 45 participants.
The verdict
NCT03305081, a NA study, was terminated before completion, sponsored by Tulane University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This a randomized control trial to identify if patients who desire LARC are more likely to have success receiving the desired form of contraception if it is placed a) during the postpartum hospital stay, either in the immediate or early postpartum period, versus b) during the interval postpartum period as previously done.
Interventions
- DEVICE Levonorgestrel IUD, copper IUD, etonorgestrel implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2014-10-22 |
| Est. Completion | 2016-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03305081
The ClinicalTrials.gov registry entry for NCT03305081 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University School of Medicine, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Levonorgestrel IUD, copper IUD, etonorgestrel implant is the first listed.
NCT03305081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03305081 about?
NCT03305081 is a clinical study titled "Patient Compliance With Long-Acting Reversible Contraception Administration". This a randomized control trial to identify if patients who desire LARC are more likely to have success receiving the desired form of contraception if it is placed a) during the postpartum hospital stay, either in the immediate or early postpartum period, versus b) during the interval postpartum per...
What is the current status of trial NCT03305081?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2014-10-22. Estimated completion is 2016-05-31.
What interventions are being tested in trial NCT03305081?
The interventions under investigation include: Levonorgestrel IUD, copper IUD, etonorgestrel implant (DEVICE).
Who is sponsoring clinical trial NCT03305081?
This trial is sponsored by Tulane University School of Medicine, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.